News & Press Releases
Filter by:
Trouble at the USPTO—Part II: Bracing for Impact
March 13, 2025
Life Science Intellectual Property Review included insights from Life Science Litigation Practice Chair and Patent Litigation Practice Co-chair Sige Gutman in an article discussing recent government efficiency initiatives impacting the US Patent and Trademark Office. The article addresses the potential implications for life sciences companies and considerations for how to navigate the current uncertainty.
Member Frank Gerratana was quoted by Business Insider about the potential implications of artificial intelligence for the billable hour.
Mintz Advises SightLine on its Acquisition of Athena AI
March 12, 2025
Mintz advised SightLine Applications, a leading developer of sensor processing software for autonomous and uncrewed systems, backed by Artemis, on its acquisition of Athena AI, an Australia-based specialist in AI-enabled computer vision and decision support for defense applications.
Retail and Consumer Products Co-chair Chuck Samuels recently connected with The Bond Buyer about potential changes to the tax-exempt status of municipal bonds. He noted that private activity bonds (PABs) and the health care and higher education sectors are among the most vulnerable to the possible changes—particularly at the local district level.
JD Supra has recognized ten Mintz attorneys in its 2025 Readers’ Choice Awards. The awards recognize attorneys and firms whose articles on the JD Supra platform were most read by C-suite executives, in-house counsel, media, and other professionals during 2024.
Mintz is a finalist for the “Life Sciences IP Firm of the Year” category in the inaugural Life Sciences Patent Network (LSPN) Awards USA 2025. The awards are organized by Life Sciences Intellectual Property Review and celebrate excellence across the industry—from trailblazing individuals to firms redefining the boundaries of life sciences IP. Judged by an independent panel of experts, the program highlights innovation, dedication, and the unsung heroes driving progress in the life sciences patent community.